Zurcher Kantonalbank (Zurich Cantonalbank) Atara Biotherapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$2.8 - $5.46 $5,020 - $9,789	-1,793 Reduced 13.31%	11,676 $33,000
Q4 2022 Feb 01, 2023	BUY	$2.85 - $5.18 $8,290 - $15,068	2,909 Added 27.55%	13,469 $44,000
Q2 2022 Aug 09, 2022	SELL	$4.69 - $9.84 $961 - $2,017	-205 Reduced 1.9%	10,560 $82,000
Q1 2022 Apr 21, 2022	SELL	$8.44 - $16.89 $6,726 - $13,461	-797 Reduced 6.89%	10,765 $100,000
Q4 2021 Feb 01, 2022	SELL	$14.7 - $19.89 $3,028 - $4,097	-206 Reduced 1.75%	11,562 $182,000
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $155 - $232	13 Added 0.11%	11,768 $211,000
Q2 2021 Jul 30, 2021	BUY	$12.89 - $16.58 $3,067 - $3,946	238 Added 2.07%	11,755 $183,000
Q1 2021 May 03, 2021	BUY	$14.0 - $20.72 $7,574 - $11,209	541 Added 4.93%	11,517 $165,000
Q4 2020 Jan 28, 2021	SELL	$12.67 - $26.23 $22,185 - $45,928	-1,751 Reduced 13.76%	10,976 $215,000
Q2 2020 Jul 28, 2020	BUY	$7.53 - $14.93 $62,062 - $123,053	8,242 Added 183.77%	12,727 $185,000
Q1 2020 May 06, 2020	BUY	$5.69 - $17.78 $10,162 - $31,755	1,786 Added 66.17%	4,485 $38,000
Q3 2019 Oct 18, 2019	BUY	$12.03 - $19.94 $12,150 - $20,139	1,010 Added 59.8%	2,699 $38,000
Q1 2019 Apr 29, 2019	SELL	$28.4 - $41.74 $11,814 - $17,363	-416 Reduced 19.76%	1,689 $67,000
Q1 2018 May 03, 2018	BUY	$18.0 - $48.35 $37,890 - $101,776	2,105 New	2,105 $82,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account